[1]
A. Jovanovska, “Clinical Significance of Minimal Residual Disease at the End of Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia”, Open Access Maced J Med Sci, vol. 7, no. 17, pp. 2818–2823, Sep. 2019.